NCT02785354View on ClinicalTrials.gov

Anticoagulants Comparative Benefit-risk Ratio in Real Life

CompletedOBSERVATIONAL
Enrollment

103,101

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

March 4, 2016

Study Completion Date

April 5, 2016

Conditions
Atrial Fibrillation
Trial Locations (1)

Unknown

1160.263.1 Boehringer Ingelheim Investigational Site, Multiple Locations

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY